Obstetrics & Gynecology Doctors in Jamaica Plain, MA Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Garo Damla, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 170 Morton Street, Lemuel Shattuck Hospital, Jamaica Plain, MA 02130 Phone: 617-522-8110

Dr. Mary Susan Schilling, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3297 Washington St, Jamaica Plain, MA 02130 Phone: 617-983-6016

Jacquelyn J Starer, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: Faulkner Hospital- 7 South, 1153 Centre Street, Jamaica Plain, MA 02130 Phone: 508-294-4866

Alice Grace Mark, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 640 Centre St, Southern Jamaica Plain Health Center, Jamaica Plain, MA 02130 Phone: 617-983-4100

News Archive

CeNeRx BioPharma awarded patent for novel compounds that selectively target peripheral cannabinoid receptors

CeNeRx BioPharma, Inc. has announced issuance of a new U.S. patent covering its novel compounds that selectively target peripheral cannabinoid receptors.

New mouse models can help scientists study MCT8 deficiency

New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.

IRIN examines HIV/AIDS response in Guinea-Bissau

IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."

Repros Therapeutics receives FDA confirmation for initiating Androxal IND

Repros Therapeutics Inc. today announced that the Company has received verbal confirmation from the Division of Metabolic and Endocrine Drug Products of the Food and Drug Agency that the Company may initiate its Investigational New Drug Application for the study of oral Androxal® in the treatment of hypogonadal men with Type II Diabetes (T2D) with a Phase IIa trial.

Numerate collaborates with Intellikine to identify drug-like inhibitors of PI3 kinase alpha

Numerate, Inc. and Intellikine, Inc. today announced the successful conclusion of their research collaboration to discover novel small molecule compounds targeting the PI3K/mTOR signaling pathway. The collaboration combined Intellikine's unique capabilities in x-ray crystal structure-guided medicinal chemistry and drug discovery with Numerate's powerful computational drug design platform to identify potent, selective and drug-like inhibitors of PI3 kinase alpha, an important target in cancer therapy.

Read more Medical News

› Verified 5 days ago